wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26776308-38AB41C1-0320-480A-A60B-FED05C477E6A
Q26776308-38AB41C1-0320-480A-A60B-FED05C477E6A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26776308-38AB41C1-0320-480A-A60B-FED05C477E6A
Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
P2860
Q26776308-38AB41C1-0320-480A-A60B-FED05C477E6A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26776308-38AB41C1-0320-480A-A60B-FED05C477E6A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3ecf772adfd1f1c37f7e5ad03c14df433acc4b3e
P2860
Con: Should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab?